Related Experiment Video
Updated: Feb 14, 2026

10:02
Whole-body PET/MRI of Pediatric Patients: The Details That Matter
Published on: December 19, 2017
15.4K
Reduced synaptic density in patients with progressive supranuclear palsy: An 18F-SynVest-1 PET study
Xiaoli Hao1, Yulai Li2, Yafei Wen1
1Department of Neurology, Xiangya Hospital Central South University, Changsha, China.
Parkinsonism & Related Disorders
|February 12, 2026
Summary
18F-SynVest-1 PET imaging reveals reduced synaptic density in progressive supranuclear palsy (PSP) patients. This novel PET tracer shows promise for early PSP detection and monitoring disease severity.
Area of Science:
- Neuroscience
- Radiology
- Medical Imaging
Background:
- Progressive supranuclear palsy (PSP) is a neurodegenerative disease marked by early synaptic loss.
- Synaptic vesicle glycoprotein 2A (SV2A) is a key marker for synaptic density.
Purpose of the Study:
- To assess synaptic density in PSP patients using 18F-SynVest-1 positron emission tomography (PET).
- To evaluate the diagnostic efficacy of 18F-SynVest-1 PET for PSP detection.
Main Methods:
- 13 PSP patients and 11 healthy controls underwent 18F-SynVest-1 PET and MRI scans.
- Voxel-based and ROI-based analyses compared synaptic density.
- Receiver operating curve (ROC) analysis assessed diagnostic accuracy.
Main Results:
- PSP patients showed significantly lower synaptic density in the midbrain, basal ganglia, thalamus, and frontal lobes (p < 0.05).
- Left caudate synaptic density distinguished PSP patients from controls with an AUC of 0.94.
- Synaptic density correlated positively with the midbrain to pons ratio in PSP patients (R=0.58, p=0.04).
Conclusions:
- 18F-SynVest-1 PET successfully visualized in vivo synaptic density changes in PSP patients for the first time.
- 18F-SynVest-1 PET demonstrates potential for early PSP detection.
- This PET tracer may aid in monitoring PSP disease severity.
Related Concept Videos
Synaptic Signaling
79.8K
Neurons communicate at synapses, or junctions, to excite or inhibit the activity of other neurons or target cells, such as muscles. Synapses may be chemical or electrical.
79.8K
Synaptic Signaling
6.7K
Neurons communicate at synapses, or junctions, to excite or inhibit the activity of other neurons or target cells, such as muscles. Synapses may be chemical or electrical.
Most synapses are chemical, meaning an electrical impulse or action potential spurs the release of chemical messengers called neurotransmitters. The neuron sending the signal is called the presynaptic neuron, and the neuron receiving the signal is the postsynaptic neuron.
The presynaptic neuron fires an action potential that...
Most synapses are chemical, meaning an electrical impulse or action potential spurs the release of chemical messengers called neurotransmitters. The neuron sending the signal is called the presynaptic neuron, and the neuron receiving the signal is the postsynaptic neuron.
The presynaptic neuron fires an action potential that...
6.7K
Reducing Line Loss
395
In a three-phase circuit, line loss is an indicator of energy dissipated as heat due to the resistance of transmission lines. To address this, incorporating transformers into the system—a step-up transformer at the source and a step-down transformer at the load—is a strategic solution. Two three-phase transformers are introduced to improve this.
With a step-up transformer at the source, the voltage is increased, thereby reducing the current in the transmission lines since power loss in...
With a step-up transformer at the source, the voltage is increased, thereby reducing the current in the transmission lines since power loss in...
395
Tumor Progression
7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
Density
20.0K
Density is an important characteristic of substances, crucial in determining whether an object sinks or floats in a fluid. Its SI unit is kg/m3, and its cgs unit is g/cm3. The density of an object helps in identifying its composition, and also reveals information about the phase of the matter and its substructure. The densities of liquids and solids are roughly comparable, consistent with the fact that their atoms are in close contact. However, gases have much lower densities than liquids and...
20.0K
Bioavailability Study Design: Healthy Subjects Versus Patients
164
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
164

